Cargando…

Circulating mir-199-3p screens the onset of type 2 diabetes mellitus and the complication of coronary heart disease and predicts the occurrence of major adverse cardiovascular events

BACKGROUND: Coronary heart disease (CHD) is a major complication of type 2 diabetes mellitus (T2DM), which causes an adverse prognosis. There is an urgent need to explore effective biomarkers to evaluate the patients’ adverse outcomes. OBJECTIVE: This study aimed to identify a novel indicator for sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Renjie, Liu, Yanwei, Zhang, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655316/ https://www.ncbi.nlm.nih.gov/pubmed/37974073 http://dx.doi.org/10.1186/s12872-023-03601-4

Ejemplares similares

Elevation of Circulating miR-210 Participates in the Occurrence and Development of Type 2 Diabetes Mellitus and Its Complications
por: Chen, Xi, et al.
Publicado: (2022)

Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention
por: Chen, Tao, et al.
Publicado: (2022)

Risk Prediction of Major Adverse Cardiovascular Events Occurrence Within 6 Months After Coronary Revascularization: Machine Learning Study
por: Wang, Jinwan, et al.
Publicado: (2022)

ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography
por: Heunisch, Fabian, et al.
Publicado: (2017)

The burden of major adverse cardiac events in patients with coronary artery disease
por: Tsai, I-Ting, et al.
Publicado: (2017)

SUN-199 A Case of Ectopic Cushing’s Syndrome with Major Complications Leading to Treatment Dilemmas
por: McCloskey, Karen, et al.
Publicado: (2020)

Effect of the index of cardiac electrophysiological balance on major adverse cardiovascular events in patients with diabetes complicated with coronary heart disease
por: Lin, Yuan, et al.
Publicado: (2023)

Association of NFKB1 gene rs28362491 mutation with the occurrence of major adverse cardiovascular events
por: Luo, Jun-Yi, et al.
Publicado: (2022)

Correlation of myocardial perfusion defects on Stress MR perfusion study with occurrence major adverse cardiac events in patients with moderate coronary artery disease
por: Bannur, Mahesha
Publicado: (2015)

Analysis between high risk of myocardial infarction with non‐obstructive coronary artery disease in single center and occurrence of major adverse cardiovascular events
por: Kong, Meihong, et al.
Publicado: (2022)

miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6
por: Hong, Soon Auck, et al.
Publicado: (2023)

Associations of Modified Healthy Aging Index With Major Adverse Cardiac Events, Major Coronary Events, and Ischemic Heart Disease
por: Huang, Ninghao, et al.
Publicado: (2023)

Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases
por: Brocco, Stefano, et al.
Publicado: (2007)

Major adverse cardiac events and drug-coated balloon size in coronary interventions
por: Naguib, David, et al.
Publicado: (2018)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

Circulating miR-627-5p and miR-199a-5p are promising diagnostic biomarkers of colorectal neoplasia
por: Zhao, Dong-Yan, et al.
Publicado: (2022)

Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome
por: Pavasini, Rita, et al.
Publicado: (2022)

Type 2 diabetes mellitus and In-hospital Major Adverse Cardiac and Cerebrovascular Events (MACCEs) and postoperative complications among patients undergoing on-pump isolated coronary artery bypass surgery in Northeastern Iran
por: Nomali, Mahin, et al.
Publicado: (2023)

Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial
por: Akrami, Mehdi, et al.
Publicado: (2021)

MicroRNA 199a Is Downregulated in Patients After Coronary Artery Bypass Graft Surgery and Is Associated with Increased Levels of Sirtuin 1 (SIRT 1) Protein and Major Adverse Cardiovascular Events at 3-Year Follow-Up
por: Yamac, Aylin Hatice, et al.
Publicado: (2018)

Predictors of major adverse cardiac events following elective stenting of large coronary arteries
por: Aghajani, Hassan, et al.
Publicado: (2018)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
por: Okkonen, Marjo, et al.
Publicado: (2021)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register
por: Vela, Paloma, et al.
Publicado: (2020)

Registration of catheter-related complications in adverse events reporting systems: a major underestimation of the real complication practice
por: Laan, Bart J, et al.
Publicado: (2021)

Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction
por: Xue, Sheng, et al.
Publicado: (2019)

A Description of the Hemolytic Component in Sickle Leg Ulcer: The Role of Circulating miR-199a-5p, miR-144, and miR-126
por: Santos, Edvan do Carmo, et al.
Publicado: (2022)

Occurrence and Impact of Gastrointestinal Bleeding and Major Adverse Cardiovascular Events during Sepsis: A 15-Year Observational Study
por: Hsieh, Ming-Shun, et al.
Publicado: (2020)

Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
por: Li, Linzi, et al.
Publicado: (2023)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Risk factors associated with the occurrence of adverse events in plateletpheresis donation
por: Barbosa, Maria Helena, et al.
Publicado: (2014)

Occurrence and preventability of adverse events in hospitals: a retrospective study
por: de Lima, Antônio José, et al.
Publicado: (2023)

The SYNTAX Score Can Predict Major Adverse Cardiac Events Following Percutaneous Coronary Intervention
por: Safarian, Hadi, et al.
Publicado: (2014)

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
por: Baluja, Aurora, et al.
Publicado: (2019)

Current Progress of Studies of Coronary CT for Risk Prediction of Major Adverse Cardiovascular Event (MACE)
por: Zheng, Jianan, et al.
Publicado: (2021)

Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
por: Fu, Liyao, et al.
Publicado: (2021)

Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
por: Zeng, Ni, et al.
Publicado: (2021)

Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis
por: Hu, Rui-ting, et al.
Publicado: (2015)

Major adverse cardiac event rates in moderate‐risk patients: Does prior coronary disease matter?
por: McGinnis, Henderson D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2napv8krfh99h3ronscvk3udq